Back to UBS Group AG UBS Group AG

IBRXIBRX
22 quarters

Position history for UBS Group AGUBS Group AG's holdings in IMMUNITYBIO INC

UBS Group AG holds 3.2M shares of IBRX (IMMUNITYBIO INC), worth $28M as of 2026-Q2. The position was increased (+8.5% shares). IBRX represents 0.0% of UBS Group AG's portfolio.

Current Value

$28M

Current Shares

3.2M

Total Value Change

+$26.6M

Total Shares Change

+3.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
3.2M
+8.5%
$28M0.0%$8.76
31
2026-Q1
Increased
2.9M
+47.6%
$22.6M0.0%$10.00
39
2025-Q4
Increased
2M
+18.7%
$4M0.0%$1.98
31
2025-Q3
Increased
1.7M
+41.1%
$4.1M0.0%$2.57
36
2025-Q2
Decreased
1.2M
-17.2%
$3.1M0.0%$2.70
0
2025-Q1
Decreased
1.4M
-9.4%
$4.3M0.0%$3.14
0
2024-Q4
Increased
1.6M
+290.6%
$4.1M0.0%$2.68
43
2024-Q3
Decreased
406,433
-11.3%
$1.5M0.0%$3.93
0
2024-Q2
Decreased
458,255
-50.5%
$2.9M0.0%$6.32
0
2024-Q1
Increased
925,489
+2066.8%
$5M0.0%$5.37
43
2023-Q4
Increased
42,712
+7.4%
$214,4140.0%$5.02
25
2023-Q3
Increased
39,782
+0.2%
$67,2310.0%$1.69
14
2023-Q2
Decreased
39,712
-65.3%
$110,3990.0%$2.72
0
2023-Q1
Decreased
114,378
-69.0%
$208,1680.0%$1.76
0
2022-Q4
Increased
368,603
+218.0%
$1.9M0.0%$5.07
42
2022-Q3
Increased
115,918
+131.5%
$576,0000.0%$4.94
39
2022-Q2
Decreased
50,073
-71.1%
$186,0000.0%$3.77
0
2022-Q1
Decreased
173,030
-51.3%
$971,0000.0%$5.89
0
2021-Q4
Increased
354,987
+27.4%
$2.2M0.0%$6.38
32
2021-Q3
Increased
278,699
+925.4%
$2.7M0.0%$9.61
42
2021-Q2
Decreased
27,179
-51.5%
$388,0000.0%$14.54
0
2021-Q1
New
56,014
-
$1.3M0.0%$23.75
35

Other major holders of IBRX: BlackRock, Inc., STATE STREET CORP, VANGUARD PORTFOLIO MANAGEMENT LLC, VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used